Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: A systematic review and meta-analysis

Line Uhrenholt*, Robin Christensen, Wilfred K. H. Dinesen, Caroline H. Liboriussen, Stine S. Andersen, Lene Dreyer, Annette Schlemmer, Ellen-Margrethe Hauge, Conni Skrubbeltrang, Peter C. Taylor, Salome Kristensen

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)
PhD thesis

Search results